OSE Immuno: six experts join the scientific council


(CercleFinance.com) – OSE Immunotherapeutics announces the appointment of six leading international experts to its new Scientific Board to support the Company in its new phase of growth and its scientific orientations.

‘We are proud to have been able to assemble a team of independent, world-renowned key opinion leaders in immunology, immuno-oncology and inflammation,’ commented Nicolas Poirier, Scientific Director of OSE Immunotherapeutics. ‘We will benefit from excellent and highly complementary expertise to continue developing our R&D skills and feed the science developed by OSE’, he added.

The Scientific Council, chaired by Professor Wolf-Hervé Fridman who will lead the discussions and reflections, is composed of:

Wolf-Hervé Fridman, President, Professor Emeritus of Immunology at the University of Paris, specialist in the analysis of the tumor micro-environment.

Sophie Brouard, Director of Research at the National Institute of Health and Medical Research (INSERM) in Nantes, immunologist and veterinarian, co-inventor of 11 patents.

Bernard Malissen, PhD, Team leader at the Marseille-Luminy Immunology Center and founder-director of the Marseille Immunophenomics Center, he is one of the most cited researchers in immunology over the past 5 years.

Myriam Merad, MD, PhD, Director of the Precision Immunology Institute at Mount Sinai School of Medicine in New York, Director of the Mount Sinai Human Immune Monitoring Center (HIMC), recognized as a ‘leader in dendritic cell and macrophage biology focused on on their role in human disease.

Charles N. Serhan, PhD, DSc, Professor of Anesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School (Massachussetts, USA), Professor of Dentistry, Infection and Immunity at Harvard Dental School ‘Harvard, he directs the Center for Experimental Therapies of Ischemia-Reperfusion Injury at Brigham and Women’s Hospital and co-directs the Brigham Research Institute.

Jennifer Wargo, MD, MMSc., Professor of Genomic Medicine & Surgical Oncology, University of Texas, MD Anderson Cancer Center, is internationally recognized as ‘a leader in cancer research and pioneering work’ .

Copyright © 2022 CercleFinance.com. All rights reserved.

Did you like this article ? Share it with your friends with the buttons below.





Facebook


LinkedIn


E-mail





Source link -85